NCI Community Oncology Research Program Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
NCI COVID-19 in Cancer Patients, NCCAPS Study Biospecimen Collection, Data Collection, Quality-of-Life Assessment, Questionnaire Administration NCT04387656 National Cancer Institute (NCI) Active, not recruiting
Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or... Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Olanzapine, Placebo, Prochlorperazine, Quality-of-Life Assessment NCT03367572 University of Rochester NCORP Research Base Recruiting
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Cognitive Assessment, Quality-of-Life Assessment NCT00772200 Children's Oncology Group Recruiting
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by... Laboratory Biomarker Analysis, Nutritional Intervention, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration NCT03757949 Southwest Oncology Group Recruiting
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer... Megestrol Acetate, Olanzapine, Questionnaire Administration NCT04939090 Alliance for Clinical Trials in Oncology Recruiting
Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and... Dexamethasone, Fosaprepitant Dimeglumine, Olanzapine, Ondansetron Hydrochloride, Palonosetron Hydrochloride, Placebo NCT03578081 Alliance for Clinical Trials in Oncology Active, not recruiting
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2... Palbociclib, Letrozole, Fulvestrant, Questionnaire Administration, Quality-of-Life Assessment NCT03633331 Alliance for Clinical Trials in Oncology Active, not recruiting
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... Endocrine therapy interruption NCT02308085 ETOP IBCSG Partners Foundation Active, not recruiting
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection... Best Practice, Entecavir, Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate NCT03887702 Southwest Oncology Group Recruiting
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who... Laboratory Biomarker Analysis, Trastuzumab, Whole Breast Irradiation NCT00769379 National Cancer Institute (NCI) Active, not recruiting

Pages